Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs

Alex C. Spyropoulos, Veronica Ashton, Yen Wen Chen, Bingcao Wu, Eric D. Peterson

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs'. Together they form a unique fingerprint.

Medicine & Life Sciences